MOBILion Systems is Diagnostic Equipment in United States that focus on biologic drug development business. Founded in 2015. They cover business area such as developer, advancement, disease prediction, diagnosis, treatment, unprecedented speed, sensitivity, resolution, population-scale sample, clinically relevant molecule, protein, peptide, metabolite, glycan, lipid, biologic drug development and biomarker discovery, researcher, clinician, medical disease.
2015
( 9 years old in 2024 )
Biologic Drug Development
-
4 Hillman Drive
Suite 130
Chadds Ford, PA 19317
United States
Private
developeradvancementdisease predictiondiagnosistreatmentunprecedented speedsensitivityresolutionpopulation-scale sampleclinically relevant moleculeproteinpeptidemetaboliteglycanlipidbiologic drug development and biomarker discoveryresearcherclinicianmedical disease
* We use standard office opening hours in near MOBILion Systems's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MOBILion Systems is Diagnostic Equipment business from United States that founded in 2015 (9 years old in 2024), MOBILion Systems business is focusing on Biologic Drug Development.
MOBILion Systems headquarter office and corporate office address is located in 4 Hillman Drive Suite 130 Chadds Ford, PA 19317 United States.
MOBILion Systems was founded in United States.
In 2024, MOBILion Systems is currently focus on biologic drug development sector.
Above is snippet of Google Trends for "biologic drug development" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MOBILion Systems, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
